Cite
HARVARD Citation
Bontempi, I. et al. (2020). Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection. Clinical and experimental immunology. pp. 306-316. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bontempi, I. et al. (2020). Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection. Clinical and experimental immunology. pp. 306-316. [Online].